How Do You Build a Go-to-Market Motion for Population Health Platforms Like Arcadia and Innovaccer in 2027?
Build the motion around where value-based payment money is moving, who signs off inside a health system or plan, and proof you can show before a pilot. Sell to risk-bearing organizations first, because that is where the platform has a job to do, and keep separate plays for providers and payers.
The demand driver is public. CMS reported on February 4, 2026 that the Shared Savings Program has 511 ACOs for performance year 2026, up from 476 in 2025, and an estimated 14.3 million people with Traditional Medicare are in ACOs. ACO REACH ends after 2026 and CMS says the LEAD Model launches in 2027.
No source used here publishes a typical sales-cycle length, deal size or market size for population health platforms, so none is given. Buying appetite is not guaranteed either: KLAS reported in 2024 that only 10% of interviewed large acute care organizations had a recent or in-progress purchase decision.
Start from the payment programs that create the buyer
The CMS fact sheet dated February 4, 2026 says the Shared Savings Program has 511 ACOs for performance year 2026, up from 476 in 2025. CMS approved 134 applications, including 72 new ACOs and 62 renewing or reentering ACOs, and these ACOs serve 12.6 million people with Traditional Medicare, a 12.3% increase. It adds that 82.8% of the ACOs are in Level E of the BASIC track or the ENHANCED track, the higher-risk tracks.
Across all CMS ACO programs, the same fact sheet estimates 14.3 million beneficiaries in ACOs as of January 2026, up from 13.7 million in 2025. ACO REACH has 74 ACOs with 125,909 health care providers and organizations, serving about 1.7 million people.
The ACO REACH page, last updated September 21, 2026, says the model runs four performance years, 2023 through 2026, and accepts no new applications. It refers to the upcoming LEAD Model, which begins January 1, 2027. The fact sheet says LEAD targets smaller, independent and rural practices and high-needs patients such as people eligible for both Medicare and Medicaid.
See how the two leaders position themselves
Arcadia (site metadata modified October 28, 2026) describes a platform that unifies EHR, claims, social determinants and other data, run in three stages: Aggregate, Transform, Activate. Its products include Arcadia Ascent, which it calls a Healthcare Performance Suite, and CareJourney, provider and network intelligence built on longitudinal claims data. It lists Provider, Payer, Life Science, ACO and Government as customer types, and shows logos including Aetna, WakeMed, Beth Israel Lahey Health and Highmark. The page gives no numeric results.
Innovaccer (copyright 2026, latest dated item July 9, 2026) describes a healthcare AI platform, Gravity, with named products including Atlas for population health and Galaxy for payer risk and quality. It lists provider, payer, public sector and life sciences industries, and names health systems such as Orlando Health, Ascension and Intermountain and ACOs such as Atlantic Health ACO. Its own stats include 1.9M value-based lives managed at CommonSpirit and a 60%+ reduction in heart failure hospitalizations at Intermountain. These are vendor claims, not independently verified.
Both sell to providers and payers and name ACOs as a customer type. The takeaway for a go-to-market plan is that the category is crowded and the positioning is about one platform that spans data, analytics and action. A new entrant has to pick a narrower job.
Map the buyer committee
No source used here describes who sits on a population health buying committee or how long the decision takes. What follows is our own reasoning from how these products work, so treat it as a hypothesis to test in discovery.
- VP of population health or value-based care. Usually the person who lives with the quality and shared-savings targets. Give them a use case tied to a program they are in.
- CFO. Cares about whether the platform supports revenue under risk contracts. Bring the contract types the customer holds and how your data supports them.
- CIO and CMIO. Will ask how data comes in from the EHRs and how clinicians see it. Have integration answers ready by name.
- Payer-side leaders. A plan buys for risk adjustment, quality and care management. It is a separate motion with its own proof, not a reskin of the provider pitch.
Lead with EHR fit and be honest about proof
An Innovaccer blog (updated April 2026, vendor-authored and ranking itself first) lists criteria it says buyers should apply: whether one platform handles MSSP, ACO REACH, ACCESS, LEAD, Medicare Advantage and commercial value-based reporting, whether FHIR-based CMS reporting is in production, and whether the vendor takes on outcome risk or sells platform-only licenses. It says Arcadia ingests data from 40+ EHR vendors and positions Arcadia for multi-EHR systems and risk-bearing organizations. Read it as a competitor's view.
Innovaccer's main site mentions working with different EMRs but names no EHR vendors. Arcadia's site says it unifies EHR data. Neither page gives a partner list we can cite, so we do not describe either company's EHR partnerships.
Use pilots, and price with care
The Innovaccer blog contrasts platform-only licensing with managed programs where the vendor carries outcome accountability. It gives no vendor price points. The only dollar figures it cites are CMS ACCESS payments of $15 to $35 per member per month with 50% withheld pending clinical outcomes, as reported by the vendor. We found no published price list for Arcadia or Innovaccer, so we give none.
Our advice: structure a pilot around one program and one measurable result, such as a defined ACO contract or a quality measure set, with a decision date agreed up front. Decide early whether you are offering software, a managed service or shared risk, because each changes who must approve it.
Respect a cooler buying market
KLAS reported on October 1, 2024 that only 10% of interviewed large acute care organizations reported a recent or in-progress population health management purchase decision. The report names vendors including Arcadia, Innovaccer, Lightbeam, Epic, Oracle Health, HealthEC, Health Catalyst, NextGen Healthcare and Azara Healthcare.
That is a 2024 reading of large acute care organizations, so it may not describe ACOs, physician groups or payers today. It does suggest that displacing a platform already in place is harder than selling to an organization entering a new program.
For the general method of building a motion around how a regulated buyer actually purchases, see our companion piece, How Do You Build a K-12 EdTech Go-to-Market Motion in 2027?
Questions people ask
How many ACOs are there in 2026?
CMS reported on February 4, 2026 that the Shared Savings Program has 511 ACOs for performance year 2026, up from 476 in 2025. ACO REACH has 74 ACOs. CMS estimates 14.3 million beneficiaries are in ACOs as of January 2026.
What replaces ACO REACH?
CMS says ACO REACH concludes after performance year 2026 and the LEAD Model launches in 2027. CMS says LEAD targets smaller, independent and rural practices and high-needs patients.
Who does a population health platform sell to?
Arcadia lists provider, payer, life science, ACO and government customer types. Innovaccer lists provider, payer, public sector and life sciences industries. Neither publishes a standard buying committee.
How long is the sales cycle, and what does it cost?
No source used here publishes a typical sales cycle, deal size or list price for Arcadia or Innovaccer, so we do not give one.
Sources
- CMS: 2026 Medicare ACO Initiatives Participation Highlights · ACO counts, beneficiaries, ACO REACH, LEAD (Feb 4, 2026)
- CMS: ACO REACH Model · Model years and LEAD start date (updated Sept 21, 2026)
- Arcadia · Products and customer types (modified Oct 28, 2026)
- Arcadia: Resources · Payer and provider content listing (read Oct 30, 2026)
- Innovaccer · Products, customers and vendor-stated results (2026)
- Innovaccer blog: Top Population Health Management Software (vendor-authored) · Buyer criteria and competitor positioning (updated Apr 2026)
- KLAS: Care Management 2024 · 10% purchase share and vendor list (Oct 1, 2024)
Figures were read from the linked pages on October 30, 2026. Vendor statistics are the vendors' own claims, and the Innovaccer blog is written by a competitor of the companies it ranks. Sections marked as our advice are opinion, not sourced fact.
Top photo: WIPO / CC BY 2.0 via Wikimedia Commons